94 related articles for article (PubMed ID: 21324487)
1. Targeting the JNK signaling pathway potentiates the antiproliferative efficacy of rapamycin in LS174T colon cancer cells.
Benoit M; Dormond-Meuwly A; Demartines N; Dormond O
J Surg Res; 2011 May; 167(2):e193-8. PubMed ID: 21324487
[TBL] [Abstract][Full Text] [Related]
2. Rapamycin-mediated FOXO1 inactivation reduces the anticancer efficacy of rapamycin.
Abdelnour-Berchtold E; Cerantola Y; Roulin D; Dormond-Meuwly A; Demartines N; Dormond O
Anticancer Res; 2010 Mar; 30(3):799-804. PubMed ID: 20392999
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activities of ATP-competitive inhibitors of mTOR in colon cancer cells.
Blaser B; Waselle L; Dormond-Meuwly A; Dufour M; Roulin D; Demartines N; Dormond O
BMC Cancer; 2012 Mar; 12():86. PubMed ID: 22401294
[TBL] [Abstract][Full Text] [Related]
4. Negative regulation by p70 S6 kinase of FGF-2-stimulated VEGF release through stress-activated protein kinase/c-Jun N-terminal kinase in osteoblasts.
Takai S; Tokuda H; Hanai Y; Harada A; Yasuda E; Matsushima-Nishiwaki R; Kato H; Ogura S; Ohta T; Kozawa O
J Bone Miner Res; 2007 Mar; 22(3):337-46. PubMed ID: 17181399
[TBL] [Abstract][Full Text] [Related]
5. EGCG-targeted p57/KIP2 reduces tumorigenicity of oral carcinoma cells: role of c-Jun N-terminal kinase.
Yamamoto T; Digumarthi H; Aranbayeva Z; Wataha J; Lewis J; Messer R; Qin H; Dickinson D; Osaki T; Schuster GS; Hsu S
Toxicol Appl Pharmacol; 2007 Nov; 224(3):318-25. PubMed ID: 17196232
[TBL] [Abstract][Full Text] [Related]
6. Inhibiting the mTOR pathway synergistically enhances cytotoxicity in ovarian cancer cells induced by etoposide through upregulation of c-Jun.
Itamochi H; Oishi T; Shimada M; Sato S; Uegaki K; Naniwa J; Sato S; Nonaka M; Terakawa N; Kigawa J; Harada T
Clin Cancer Res; 2011 Jul; 17(14):4742-50. PubMed ID: 21610153
[TBL] [Abstract][Full Text] [Related]
7. Combination of rapamycin and garlic-derived S-allylmercaptocysteine induces colon cancer cell apoptosis and suppresses tumor growth in xenograft nude mice through autophagy/p62/Nrf2 pathway.
Li S; Yang G; Zhu X; Cheng L; Sun Y; Zhao Z
Oncol Rep; 2017 Sep; 38(3):1637-1644. PubMed ID: 28737825
[TBL] [Abstract][Full Text] [Related]
8. Dual inhibition of PI3K and mTOR mitigates compensatory AKT activation and improves tamoxifen response in breast cancer.
Chen X; Zhao M; Hao M; Sun X; Wang J; Mao Y; Zu L; Liu J; Shen Y; Wang J; Shen K
Mol Cancer Res; 2013 Oct; 11(10):1269-78. PubMed ID: 23814023
[TBL] [Abstract][Full Text] [Related]
9. Targeting the Janus-activated kinase-2-STAT3 signalling pathway in pancreatic cancer using the HSP90 inhibitor ganetespib.
Nagaraju GP; Mezina A; Shaib WL; Landry J; El-Rayes BF
Eur J Cancer; 2016 Jan; 52():109-19. PubMed ID: 26682870
[TBL] [Abstract][Full Text] [Related]
10. Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt.
Yang L; Dan HC; Sun M; Liu Q; Sun XM; Feldman RI; Hamilton AD; Polokoff M; Nicosia SV; Herlyn M; Sebti SM; Cheng JQ
Cancer Res; 2004 Jul; 64(13):4394-9. PubMed ID: 15231645
[TBL] [Abstract][Full Text] [Related]
11. Cordycepin induces apoptosis by caveolin-1-mediated JNK regulation of Foxo3a in human lung adenocarcinoma.
Joo JC; Hwang JH; Jo E; Kim YR; Kim DJ; Lee KB; Park SJ; Jang IS
Oncotarget; 2017 Feb; 8(7):12211-12224. PubMed ID: 28099944
[TBL] [Abstract][Full Text] [Related]
12. Role of AMP-activated protein kinase activators in antiproliferative multi-drug pituitary tumour therapies: effects of combined treatments with compounds affecting the mTOR-p70S6 kinase axis in cultured pituitary tumour cells.
Tulipano G; Faggi L; Cacciamali A; Spinello M; Cocchi D; Giustina A
J Neuroendocrinol; 2015 Jan; 27(1):20-32. PubMed ID: 25323047
[TBL] [Abstract][Full Text] [Related]
13. A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells.
Sekulić A; Hudson CC; Homme JL; Yin P; Otterness DM; Karnitz LM; Abraham RT
Cancer Res; 2000 Jul; 60(13):3504-13. PubMed ID: 10910062
[TBL] [Abstract][Full Text] [Related]
14. Mammalian target of rapamycin is activated in human gastric cancer and serves as a target for therapy in an experimental model.
Lang SA; Gaumann A; Koehl GE; Seidel U; Bataille F; Klein D; Ellis LM; Bolder U; Hofstaedter F; Schlitt HJ; Geissler EK; Stoeltzing O
Int J Cancer; 2007 Apr; 120(8):1803-10. PubMed ID: 17230506
[TBL] [Abstract][Full Text] [Related]
15. Marked activity of irinotecan and rapamycin combination toward colon cancer cells in vivo and in vitro is mediated through cooperative modulation of the mammalian target of rapamycin/hypoxia-inducible factor-1alpha axis.
Pencreach E; Guérin E; Nicolet C; Lelong-Rebel I; Voegeli AC; Oudet P; Larsen AK; Gaub MP; Guenot D
Clin Cancer Res; 2009 Feb; 15(4):1297-307. PubMed ID: 19190131
[TBL] [Abstract][Full Text] [Related]
16. IL-1 and TNF induction of matrix metalloproteinase-3 by c-Jun N-terminal kinase in trabecular meshwork.
Hosseini M; Rose AY; Song K; Bohan C; Alexander JP; Kelley MJ; Acott TS
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1469-76. PubMed ID: 16565381
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotection against focal ischemic brain injury by inhibition of c-Jun N-terminal kinase and attenuation of the mitochondrial apoptosis-signaling pathway.
Gao Y; Signore AP; Yin W; Cao G; Yin XM; Sun F; Luo Y; Graham SH; Chen J
J Cereb Blood Flow Metab; 2005 Jun; 25(6):694-712. PubMed ID: 15716857
[TBL] [Abstract][Full Text] [Related]
18. BEX2 promotes tumor proliferation in colorectal cancer.
Hu Y; Xiao Q; Chen H; He J; Tan Y; Liu Y; Wang Z; Yang Q; Shen X; Huang Y; Yuan Y; Ding K
Int J Biol Sci; 2017; 13(3):286-294. PubMed ID: 28367093
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of tumor growth, angiogenesis, and tumor cell proliferation by a small molecule inhibitor of c-Jun N-terminal kinase.
Ennis BW; Fultz KE; Smith KA; Westwick JK; Zhu D; Boluro-Ajayi M; Bilter GK; Stein B
J Pharmacol Exp Ther; 2005 Apr; 313(1):325-32. PubMed ID: 15626722
[TBL] [Abstract][Full Text] [Related]
20. Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo.
Hsu YL; Cho CY; Kuo PL; Huang YT; Lin CC
J Pharmacol Exp Ther; 2006 Aug; 318(2):484-94. PubMed ID: 16632641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
